Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer

• John K. Chan,
• David S. Lakomy,
• Yassmina McDonald,
• Daniel S Kapp

Affiliations

John K. Chan

Division of Gynecologic Oncology, Palo Alto Medical Foundation / California Pacific / Sutter Research Institute, Palo Alto, CA, USA; Corresponding author at: Division of Gynecologic Oncology, Palo Alto Medical Foundation / California Pacific / Sutter Research Institute, 1100 Van Ness Avenue, Floor 4, San Francisco, CA 94109, USA.

David S. Lakomy

Dartmouth Geisel School of Medicine, Dartmouth College, Hanover, NH, USA

Yassmina McDonald

Division of Gynecologic Oncology, Palo Alto Medical Foundation / California Pacific / Sutter Research Institute, Palo Alto, CA, USA

Daniel S Kapp

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA